| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030
Growth of prostatic epithelial cells is androgen-dependent; however, the mechanism of androgen action on cell growth is not well defined. We investigated whether androgen-dependent prostatic epithelial cell growth is mediated by androgen regulation of expression of genes controlling cell cycle progression. For this purpose, we used an androgen-dependent prostatic cancer cell line, LNCaP-FGC, as an in vitro model. We found that expression of CDK2 and CDK4 genes were up-regulated within hours of androgen treatment as detected in Northern and Western blot analyses. Kinase assay also confirmed that there was increased CDK2 kinase activity upon androgen stimulation. Moreover, androgen down-regulated expression of the cyclin-dependent kinase inhibitor p16 (MTS1, CDKN2) gene. The overall effects of these androgen actions result in an increased cyclin-dependent kinase activity and stimulation of the cell to enter S phase of the cell cycle, thereby enhancing cell proliferation. In contrast, an androgen-independent PC-3 cell line lost its response to androgen stimulation, and higher basal levels of CDK2, CDK4, and p16 genes were constitutively expressed in PC-3 cells. Collectively, these data suggest a possible signaling pathway of androgen in stimulating cell growth. These results also imply that in androgen-dependent prostate cancer, increased androgen receptor (AR) activity, resulting from AR gain-of-function mutations, AR gene amplification, or AR gene overexpression, malignantly stimulates proliferation of prostatic epithelial cells and constitutes one possible mechanism of androgen-dependent tumorigenesis.
1 Supported by Baylor Specialized Programs of Research Excellence (Grant CA58204).
2 To whom requests for reprints should be addressed.
Received 5/20/97. Accepted 8/16/97.
This article has been cited by other articles:
|
|
 |
|
  A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston, and D. J. J. Waugh Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation Carcinogenesis, June 1, 2008; 29(6): 1148 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Neuwirt, M. Puhr, I. T Cavarretta, M. Mitterberger, A. Hobisch, and Z. Culig Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion Endocr. Relat. Cancer, December 1, 2007; 14(4): 1007 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sharma, C. E.S. Comstock, E. S. Knudsen, K. H. Cao, J. K. Hess-Wilson, L. M. Morey, J. Barrera, and K. E. Knudsen Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Response in Prostate Cancer Cells Cancer Res., July 1, 2007; 67(13): 6192 - 6203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kwabi-Addo, W. Chung, L. Shen, M. Ittmann, T. Wheeler, J. Jelinek, and J.-P. J. Issa Age-Related DNA Methylation Changes in Normal Human Prostate Tissues Clin. Cancer Res., July 1, 2007; 13(13): 3796 - 3802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J Burd, L. M Morey, and K. E Knudsen Androgen receptor corepressors and prostate cancer Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhou, H. Wu, P. Lee, and Z. Wang Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells. J. Mol. Endocrinol., October 1, 2006; 37(2): 283 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xu, S.-Y. Chen, K. N. Ross, and S. P. Balk Androgens Induce Prostate Cancer Cell Proliferation through Mammalian Target of Rapamycin Activation and Post-transcriptional Increases in Cyclin D Proteins. Cancer Res., August 1, 2006; 66(15): 7783 - 7792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Berger, D. I. Lin, M. Nieto, E. Sicinska, L. A. Garraway, H. Adams, S. Signoretti, W. C. Hahn, and M. Loda Androgen-Dependent Regulation of Her-2/neu in Prostate Cancer Cells Cancer Res., June 1, 2006; 66(11): 5723 - 5728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Asirvatham, M. Schmidt, B. Gao, and J. Chaudhary Androgens Regulate the Immune/Inflammatory Response and Cell Survival Pathways in Rat Ventral Prostate Epithelial Cells Endocrinology, January 1, 2006; 147(1): 257 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H Walker and J. Cheng FSH and testosterone signaling in Sertoli cells Reproduction, July 1, 2005; 130(1): 15 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. S. Shah, J. Arlotti, R. Dhir, S. Lu, G. Pirozzi, K. Prakash, and R. H. Getzenberg Androgen Regulation of JM-27 Is Associated With the Diseased Prostate J Androl, July 1, 2004; 25(4): 618 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Adhami, N. Ahmad, and H. Mukhtar Molecular Targets for Green Tea in Prostate Cancer Prevention J. Nutr., July 1, 2003; 133(7): 2417S - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Li, H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR Mol. Cell. Biol., January 1, 2003; 23(1): 104 - 118. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Chen, N. Lamharzi, N. S. Weiss, R. Etzioni, D. A. Dightman, M. Barnett, D. DiTommaso, and G. Goodman Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1033 - 1040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xia, D. Robinson, A.-H. Ma, H.-C. Chen, F. Wu, Y. Qiu, and H.-J. Kung Identification of Human Male Germ Cell-associated Kinase, a Kinase Transcriptionally Activated by Androgen in Prostate Cancer Cells J. Biol. Chem., September 13, 2002; 277(38): 35422 - 35433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Venkateswaran, L. H. Klotz, and N. E. Fleshner Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines Cancer Res., May 1, 2002; 62(9): 2540 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cinar, K. S. Koeneman, M. Edlund, G. S. Prins, H. E. Zhau, and L. W. K. Chung Androgen Receptor Mediates the Reduced Tumor Growth, Enhanced Androgen Responsiveness, and Selected Target Gene Transactivation in a Human Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(19): 7310 - 7317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium PNAS, September 4, 2001; (2001) 191235898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hobisch, R. Ramoner, D. Fuchs, S. Godoy-Tundidor, G. Bartsch, H. Klocker, and Z. Culig Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype Clin. Cancer Res., September 1, 2001; 7(9): 2941 - 2948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Taplin and S.-M. Ho The Endocrinology of Prostate Cancer J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477. [Full Text] [PDF]
|
|
|
|
|
|
G. Buchanan, N. M. Greenberg, H. I. Scher, J. M. Harris, V. R. Marshall, and W. D. Tilley Collocation of Androgen Receptor Gene Mutations in Prostate Cancer Clin. Cancer Res., May 1, 2001; 7(5): 1273 - 1281. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. F. Modiano, J. Mayor, C. Ball, M. K. Fuentes, and D. S. Linthicum CDK4 Expression and Activity Are Required for Cytokine Responsiveness in T Cells J. Immunol., December 15, 2000; 165(12): 6693 - 6702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bonaccorsi, V. Carloni, M. Muratori, A. Salvadori, A. Giannini, M. Carini, M. Serio, G. Forti, and E. Baldi Androgen Receptor Expression in Prostate Carcinoma Cells Suppresses {alpha}6{beta}4 Integrin-Mediated Invasive Phenotype Endocrinology, September 1, 2000; 141(9): 3172 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yamamoto, Y. Hashimoto, K. Kohri, E. Ogata, S.-a. Kato, K. Ikeda, and M. Nakanishi Cyclin E As a Coactivator of the Androgen Receptor J. Cell Biol., August 21, 2000; 150(4): 873 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lu, G. Jenster, and D. E. Epner Androgen Induction of Cyclin-Dependent Kinase Inhibitor p21 Gene: Role of Androgen Receptor and Transcription Factor Sp1 Complex Mol. Endocrinol., May 1, 2000; 14(5): 753 - 760. [Abstract] [Full Text]
|
|
|
|
|
|
B. A. Usmani, R. Shen, M. Janeczko, C. N. Papandreou, W.-H. Lee, W. G. Nelson, J. B. Nelson, and D. M. Nanus Methylation of the Neutral Endopeptidase Gene Promoter in Human Prostate Cancers Clin. Cancer Res., May 1, 2000; 6(5): 1664 - 1670. [Abstract] [Full Text]
|
|
|
|
|
|
S. Lu, S. Y. Tsai, and M.-J. Tsai Molecular Mechanisms of Androgen-Independent Growth of Human Prostate Cancer LNCaP-AI Cells Endocrinology, November 1, 1999; 140(11): 5054 - 5059. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ye, J. Mendelsohn, and Z. Fan Androgen and Epidermal Growth Factor Down-Regulate Cyclin-dependent Kinase Inhibitor p27Kip1 and Costimulate Proliferation of MDA PCa 2a and MDA PCa 2b Prostate Cancer Cells Clin. Cancer Res., August 1, 1999; 5(8): 2171 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zi and R. Agarwal Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention PNAS, June 22, 1999; 96(13): 7490 - 7495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gupta, N. Ahmad, R. R. Mohan, M. M. Husain, and H. Mukhtar Prostate Cancer Chemoprevention by Green Tea: In Vitro and in Vivo Inhibition of Testosterone-mediated Induction of Ornithine Decarboxylase Cancer Res., May 1, 1999; 59(9): 2115 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Lee, P. Capodieci, I. Osman, M. Fazzari, J. Ferrara, H. I. Scher, and C. Cordon-Cardo Overexpression of the Cyclin-dependent Kinase Inhibitor p16 Is Associated with Tumor Recurrence in Human Prostate Cancer Clin. Cancer Res., May 1, 1999; 5(5): 977 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lu, M. Liu, D. E. Epner, S. Y. Tsai, and M.-J. Tsai Androgen Regulation of the Cyclin-Dependent Kinase Inhibitor p21 Gene through an Androgen Response Element in the Proximal Promoter Mol. Endocrinol., March 1, 1999; 13(3): 376 - 384. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Kokontis, N. Hay, and S. Liao Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest Mol. Endocrinol., July 1, 1998; 12(7): 941 - 953. [Abstract] [Full Text]
|
|
|
|
|
|
M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium PNAS, September 11, 2001; 98(19): 10823 - 10828. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
